Compile Data Set for Download or QSAR
Report error Found 614 Enz. Inhib. hit(s) with all data for entry = 9110
TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322718(2-(1-(4-((2-(azocan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322718(2-(1-(4-((2-(azocan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322715(2-(azepan-1-yl)-4-((4-((4-methylpiperazin- 1-yl)me...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322714(2-(azepan-1-yl)-4-((4-((4-(2-hydroxy-2- methylprop...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322711(6-(4-((2-cycloheptyl-5-oxo-5,6- dihydropyrimido[4,...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322726(2-(1-(2-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyr...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322726(2-(1-(2-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyr...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322722(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimido[...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM442832(US10647720, Ex. # 91)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322735(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322734(2-(azepan-1-yl)-4-((4-(piperazine-1- carbonyl)phen...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322735(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM442844(US10647720, Ex. # 114 | US10647720, Ex. # 103)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM442844(US10647720, Ex. # 114 | US10647720, Ex. # 103)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322729(2-(1-(5-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322742(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM442844(US10647720, Ex. # 114 | US10647720, Ex. # 103)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322710(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322739(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322738(2-(1-(5-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322740(2-(azepan-1-yl)-4-((4-(((2S,5S)-5- (hydroxymethyl)...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322739(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322719(US10183944, Example 89 | US10183944, Example 107 |...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322738(2-(1-(5-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322753(2-((1S,4S)-4-(4-((2-(azepan-1-yl)-5-oxo- 5,6-dihyd...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322748(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322747(2-(1-(4-((2-(3,5-dimethylpiperidin-1-yl)- 5-oxo-5,...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322760(3-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322759(2-((1R,4R)-4-(4-((2-(azepan-1-yl)-5-oxo- 5,6-dihyd...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322761(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322760(3-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322759(2-((1R,4R)-4-(4-((2-(azepan-1-yl)-5-oxo- 5,6-dihyd...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322755(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322754((2R,5S)-5-((4-((2-(azepan-1-yl)-5-oxo- 5,6-dihydro...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322753(2-((1S,4S)-4-(4-((2-(azepan-1-yl)-5-oxo- 5,6-dihyd...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322755(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322754((2R,5S)-5-((4-((2-(azepan-1-yl)-5-oxo- 5,6-dihydro...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322770(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322769(2-(azepan-1-yl)-4-((4-(4-(2- hydroxypropan-2-yl)pi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322765(6-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimido[...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322765(6-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimido[...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322764(6-(5-((2-azepan-1-yl)-5-oxo-5,6- dihydropyrimido[4...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322761(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322762(3-(1-(4-((5-oxo-2-phenyl-5,6- dihydropyrimido[4,5-...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322777(3-(1-(4-((2-(4-(cyanomethyl)piperidin-1- yl)-5-oxo...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322775(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322776(2-(1-(4-((4-(4-(2-hydroxypropan-2-yl) piperidin-1-...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322775(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322772(2-(1-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asan Biosciences

US Patent
LigandPNGBDBM322770(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
US Patent

Displayed 1 to 50 (of 614 total ) | Next | Last >>
Jump to: